Meridian Management CO Marker Therapeutics, Inc. Transaction History

Meridian Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.26 - $0.46 $5,085 - $8,997	-19,559 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$0.37 - $1.0 $7,236 - $19,559	19,559 New	19,559 $9,000
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $36,770 - $69,630	-19,559 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$1.47 - $3.29 $2,568 - $5,747	1,747 Added 9.81%	19,559 $44,000
Q2 2020 Jul 13, 2020	BUY	$1.69 - $2.79 $2,217 - $3,660	1,312 Added 7.95%	17,812 $37,000
Q1 2020 May 07, 2020	BUY	$1.59 - $3.35 $7,552 - $15,912	4,750 Added 40.43%	16,500 $31,000
Q4 2019 Feb 11, 2020	BUY	$2.68 - $4.85 $31,490 - $56,987	11,750 New	11,750 $34,000

472K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $298M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Meridian Management CO, based on Form 13F filings with the SEC.

Stay updated on Meridian Management CO with notifications on news.